Tumor‐derived EVs enriched with proteases, including a variety of MMP (MMP14, MMP9, MMP13, MMP1, and MMP3), as well as the ADAM family of disintegrins, can regulate the ECM, thereby favoring tumor progression, as described in detail by Nawaz et al.145. This evidence concerns the gene MMP3 and neoplasm.